These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2574949)

  • 1. Sympathetic nervous system during converting enzyme inhibition.
    Crozier IG; Teoh R; Kay R; Nicholls MG
    Am J Med; 1989 Dec; 87(6B):29S-32S. PubMed ID: 2574949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sympathetic nervous system and converting enzyme inhibition.
    Ball SG
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S17-21. PubMed ID: 2474095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure.
    Grassi G; Cattaneo BM; Seravalle G; Lanfranchi A; Pozzi M; Morganti A; Carugo S; Mancia G
    Circulation; 1997 Aug; 96(4):1173-9. PubMed ID: 9286946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibition, the sympathetic nervous system, and congestive heart failure. The Australian Zestril (Lisinopril) Study Group.
    Sloman G
    Am J Cardiol; 1992 Oct; 70(10):113C-118C. PubMed ID: 1329466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of sympathetic control by ACE inhibitors.
    Dominiak P
    Eur Heart J; 1993 Nov; 14 Suppl I():169-72. PubMed ID: 8293770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients.
    Lambert GW; Kaye DM; Lefkovits J; Jennings GL; Turner AG; Cox HS; Esler MD
    Circulation; 1995 Oct; 92(7):1813-8. PubMed ID: 7545554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracoronary blockade of angiotensin-converting enzyme in humans: interaction with cardiac sympathetic neurotransmission?
    Rundqvist B; Eisenhofer G; Emanuelsson H; Albertsson P; Friberg P
    Acta Physiol Scand; 1997 Sep; 161(1):15-22. PubMed ID: 9381945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE inhibition improves cardiac NE uptake and attenuates sympathetic nerve terminal abnormalities in heart failure.
    Kawai H; Fan TH; Dong E; Siddiqui RA; Yatani A; Stevens SY; Liang CS
    Am J Physiol; 1999 Oct; 277(4):H1609-17. PubMed ID: 10516201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Converting enzyme inhibition modulates sympathetic neurotransmission in vivo via multiple mechanisms.
    Schwieler JH; Kahan T; Nussberger J; Hjemdahl P
    Am J Physiol; 1993 Apr; 264(4 Pt 1):E631-7. PubMed ID: 8386457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme inhibition and sympathetic activity in healthy subjects.
    Lang CC; Stein CM; He HB; Wood AJ
    Clin Pharmacol Ther; 1996 Jun; 59(6):668-74. PubMed ID: 8681492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sympathetic nervous system and ischaemic heart disease.
    Remme WJ
    Eur Heart J; 1998 Jun; 19 Suppl F():F62-71. PubMed ID: 9651738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurohormonal activation and the response to converting enzyme inhibitors in congestive heart failure.
    Kubo SH
    Circulation; 1990 Feb; 81(2 Suppl):III107-14. PubMed ID: 2137052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: effect of ACE inhibitors and other vasodilators].
    Langes K; Bleifeld W
    Herz; 1990 Jun; 15(3):164-70. PubMed ID: 2198217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertensive mechanisms and converting enzyme inhibitors.
    Ferrario CM; Jaiswal N; Yamamoto K; Diz DI; Schiavone MT
    Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV56-62; discussion IV83-90. PubMed ID: 1893643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-(1-7) modulates vascular resistance and sympathetic neurotransmission in kidneys of spontaneously hypertensive rats.
    Stegbauer J; Oberhauser V; Vonend O; Rump LC
    Cardiovasc Res; 2004 Feb; 61(2):352-9. PubMed ID: 14736552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and chronic converting enzyme inhibition reduces the vasomotor response to reflex sympathetic activation in man.
    Morganti A; Grassi G; Sala C; Capozi A; Turolo L; Sabadini E; Bolla G; Mancia G; Zanchetti A
    J Hypertens Suppl; 1985 Dec; 3(3):S259-62. PubMed ID: 2856713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of angiotensin-converting enzyme inhibition on sympathetic neurotransmission: possible roles of bradykinin and prostaglandins.
    Schwieler JH; Hjemdahl P
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S39-46. PubMed ID: 1282628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulatory and extracirculatory effects of angiotensin-converting enzyme inhibition.
    Weber MA; Neutel JM; Smith DH
    Am Heart J; 1992 May; 123(5):1414-20. PubMed ID: 1575168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction.
    Ahmad M; White R; Tan J; Huang BS; Leenen FH
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):565-72. PubMed ID: 18496146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure.
    Adams KF
    Am J Health Syst Pharm; 2004 May; 61 Suppl 2():S4-13. PubMed ID: 15160833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.